FDI in pharmaceuticals: The state of play
The pharmaceutical industry suffered a dip in FDI in 2020 as the Covid-19 pandemic hit, but did any countries manage…
By
Investment
Latest in
Investment
Pfizer plans $120m investment for Covid-19 oral drug manufacturing in US
The latest expansion will create more than 250 new high-skilled manufacturing jobs at the company’s Kalamazoo facility.
Pfizer plans to halt additional investments in Russia amid Ukraine crisis
The company does not anticipate any supply chain disruptions or price pressure due to the Russia-Ukraine crisis.
GSK’s top scientist to quit, become CEO of anti-ageing start-up
GSK’s chief scientific officer, Hal Barron, will head up the Silicon Valley biotech Altos Labs.
By
UK life sciences trade group calls for oral Covid-19 antiviral investment
The UK government must invest in Covid-19 antiviral treatments like it did with vaccines, said the chair of the UK…
By
Vaccibody rebrands to Nykode and bags $925m deal with Regeneron
Norwegian vaccine and immunotherapy-focused biopharma Vaccibody has rebranded to Nykode after signing a nearly $1bn deal.
By
AION Labs Q&A: driving innovation in pharma AI
AION Labs will create and invest in early-stage start-ups developing AI and computational solutions to major challenges in pharma.
By
Global warning: pharma’s role in the climate crisis
With COP26 imminent, what lessons can the pharma sector learn about its environmental impact and its response to climate change?
By